CD274 and neoplasm: All mice in the combined group were tumor-free, and the relative tumor weight compared to control in the groups of anti-PD-L1 and 4-1BB agonist antibody were 20.7 ± 4.1% and 33.9 ± 27.5% respectively (Figure 1C).